Please ensure Javascript is enabled for purposes of website accessibility

Welcome to Regulatory Rapporteur. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
topra-logo

The Organisation for Professionals in Regulatory Affairs
Site name
Mast navigation
  • Become a member
  • Sign in
Search our site
Menu
Close menu
  • Regulatory Rapporteur - July/August 2025
  • Pharmaceuticals
    • Back to parent navigation item
    • Pharmaceuticals
    • Artificial intelligence
    • ATMP
    • Biologics
    • Chemistry, manufacturing and controls
    • Clinical trials
    • Non-clinical development
    • Oncology
    • Product information
    • Regulatory procedures
  • Veterinary
  • Medical devices
    • Back to parent navigation item
    • Medical devices
    • Combination products
    • In-vitro diagnostics
    • Software
    • Artificial intelligence
  • Industry news
    • Back to parent navigation item
    • Industry news
    • Industry news
      • Back to parent navigation item
      • Industry news
      • Read latest news
      • Video
  • Commentary
    • Back to parent navigation item
    • Commentary
    • Editorials
    • Letters to the Editor
    • Podcasts
  • Collections
    • Back to parent navigation item
    • Collections
    • Interviews
    • Symposium 2024
      • Back to parent navigation item
      • Symposium 2024
      • Annual lecture
    • Symposium 2023
      • Back to parent navigation item
      • Symposium 2023
      • Annual lecture
    • Symposium 2022
      • Back to parent navigation item
      • Symposium 2022
      • Annual lecture
    • Symposium 2021
      • Back to parent navigation item
      • Symposium 2021
      • Annual lecture
    • CPD supplements
      • Back to parent navigation item
      • CPD supplements
      • 2021/2022
      • 2020
      • 2019
  • JOIN TOPRA
  • topra-logo

    The Organisation for Professionals in Regulatory Affairs
  • Regulatory Rapporteur - July/August 2025
  • Pharmaceuticals
      • Artificial intelligence
      • ATMP
      • Biologics
      • Chemistry, manufacturing and controls
      • Clinical trials
      • Non-clinical development
      • Oncology
      • Product information
      • Regulatory procedures
    • Diversity licensed image
      ​Diversity in clinical research: Regulatory considerations and updates
    • EUPATI licensed image
      Patient involvement in the regulatory area: Insights into national level dialogues
    • PPI licensed image
      ​The evolving landscape of public and patient involvement
  • Veterinary
    • RR-June-2025-half cover _masthead
      June 2025 – Contents
    • June cover image licensed
      Veterinary medicines: Translating regulation into practice
    • RR-Nov-2024-Half-Cover
      November 2024 – Contents: Veterinary medicines sessions
    • SUSIMPERATIVE_compressed
      The sustainability imperative for the healthcare sector
  • Medical devices
      • Combination products
      • In-vitro diagnostics
      • Software
      • Artificial intelligence
    • MDR-innovation-compressed
      The EU Medical Device Regulation: Balancing innovation with regulation
    • final licensed cover image_compressed
      Medical device regulation: Challenges, innovation and the future
    • RR-Nov-2024-Half-Cover
      November 2024 – Contents: Medical devices/IVDs sessions
  • Industry news
      • Industry news
        • Read latest news
        • Video
    • PILOT licensed image
      Extension to ​ICMRA post-approval change collaborative pilots
    • AdobeStock_521314530_Editorial_Use_Only
      NHS app opens access to trials for UK patients
    • licensed EMA PMS news image
      Updated post-market surveillance requirements take effect
  • Commentary
      • Editorials
      • Letters to the Editor
      • Podcasts
    • RR issue cover licensed final
      Patient voice: Shaping the future of medicine regulation
    • TOPRA FAMHP Podcast 800x533px (6.4 ratio) V1
      RegRapPod − InConversation with Hugues Malonne
    • June cover image licensed
      Veterinary medicines: Translating regulation into practice
  • Collections
      • Interviews
      • Symposium 2024
        • Annual lecture
      • Symposium 2023
        • Annual lecture
      • Symposium 2022
        • Annual lecture
      • Symposium 2021
        • Annual lecture
      • CPD supplements
        • 2021/2022
        • 2020
        • 2019
    • Banner_new
      Streamline medical device compliance with BSI Compliance NavigatorSponsored by The UK's National Standards Body
    • AdobeStock_59790119
      The Olaratumab experience
    • AdobeStock_207448226
      Qualification of stride velocity endpoint in Duchenne Muscular Dystrophy
  • JOIN TOPRA
  • More from navigation items
Pharmaceuticals

November 2024 – Contents

  • No comments

 

RR-Nov-2024-Half-Cover

Regulatory
Rapporteur

 

Write to the Editor at publications@topra.org

November 2024  |  Vol. 21  |  No. 10

 

EDITORIAL

Improving health outcomes through regulatory excellence

Cover option 1 MichaelKipping

READ HERE

By Kornelia Grein, Sobhey Nassar and Marie Uguen

 

HUMAN MEDICINES

Human medicines sessions

SabineHaubenreisser

READ THE SESSION SUMMARIES HERE

 

MEDICAL DEVICES/IVDS

Medical devices/IVDs sessions   

MD1 -MargarethJorvid

READ THE SESSION SUMMARIES HERE

 

VETERINARY MEDICINES

Veterinary medicines sessions

VM1 - RickClayton

READ THE SESSION SUMMARIES HERE

 

PARALLEL SESSION

PS1: Resolving specific development hurdles via scientific advice

PS1 - SandraLourenço

READ HERE

By Ophélie Poujade

 

PARALLEL SESSION

PS2: Patient experience data – The next steps towards medicines evaluation

PS2 - JuanGarciaBurgos

READ HERE

By Anna Koptina

 

SME, ACADEMIA AND START-UPS

SME: Regulatory updates for SME, academia and start-ups

SME -MarjonPasmooij

READ HERE

By Marie Uguen

 

ANNUAL LECTURE

The TOPRA annual lecture: Status of global health  

AnnualLecture - IlonaKickbusch

READ HERE

By Margareth Jorvid

 

Topics

  • 2024
  • Human medicines
  • IVD
  • Medical Devices
  • November 2024
  • Pharmaceuticals
  • Symposium 2024
  • Veterinary
  • No comments

More from Pharmaceuticals

  • AnnualLecture - IlonaKickbusch
    Journal

    TOPRA annual lecture: Status of global health

    2024-11-08T06:55:00Z

    By Margareth Jorvid

  • HM9 - ChristineGrew
    Journal

    HM9: Clinical trial applications - EU Clinical Trial Regulation and beyond

    2024-11-08T06:53:00Z

    By Christine Grew

  • HM8 - CarlosLangezaal
    Journal

    HM8: How the new EU regulation on health technology assessment (HTA) will change clinical drug development and regulatory affairs

    2024-11-08T06:53:00Z

    By David Uguen

  • HM6 - RebeccaLumsden
    Journal

    HM6: Artificial Intelligence – How will AI and machine learning tools transform regulatory practice?

    2024-11-08T06:52:00Z

    By Natasha Bankowski

  • HM7 - Denise Umuhire
    Journal

    HM7: Clinical evidence generation in Europe – Is it time for a more holistic view of global healthcare product development?

    2024-11-08T06:52:00Z

    By Michelle Blake

  • HM1 - SabineHaubenreisser
    Journal

    HM1: Ensuring regulatory excellence

    2024-11-08T06:51:00Z

    By Sandra Lourenço

Related articles

  • FDAMANU licensed
    Journal

    FDA comparability guidance: The impact of cell and gene therapy products

    2025-07-11T10:26:00Z

    By Hao Liu, Laura Guijarro, Rajenda Kunda and Slobodanka Cirin-Varadjan

  • Diversity licensed image
    Journal

    ​Diversity in clinical research: Regulatory considerations and updates

    2025-07-11T10:23:00Z

    By Heidi Stauffer-McDonald and Sean Schofield

  • ODD licensed image (2)
    Journal

    ​The importance of patient advocacy in the EMA ODD process

    2025-07-11T10:22:00Z

    By Catherine Moncad

  • EUPATI licensed image
    Journal

    Patient involvement in the regulatory area: Insights into national level dialogues

    2025-07-11T10:22:00Z

    By Maria Dutarte and Birka Lehmann

  • PRAGMATIC licensed image
    Journal

    ​Realising opportunities to generate RWE for regulatory decisions through randomised pragmatic trials

    2025-07-11T10:22:00Z

    By EFPIA

  • PPI licensed image
    Journal

    ​The evolving landscape of public and patient involvement

    2025-07-11T10:21:00Z

    By Mandy Daly

No comments yet

You're not signed in.

Only registered users can comment on this article.

Sign in Register
  • What is Regulatory Affairs?
  • TOPRA Membership
  • Regulatory Rapporteur Editorial Board
  • Regulatory Rapporteur Editorial Area
  • Future Focus Topics
  • FAQs
  • Glossary
  • Privacy Policy
  • ISSN 2755-5070 (online)

    ISSN 1742-8955 (print - legacy)

Regulatory Rapporteur

The peer-reviewed journal, published 11 times per year and available free to TOPRA members.

Follow TOPRA
topra-logo

The Organisation for Professionals in Regulatory Affairs

TOPRA office
TOPRA Publishing, Third floor, City Reach, 5 Greenwich View Place, London E14 9NN, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org

TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70

  • Contact us
  • Copyright © 2015-2025 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved

Site powered by Webvision Cloud